Literature DB >> 8078509

Long lasting anti-adrenergic effect of 7-oxo-prostacyclin in the heart: a cycloheximide sensitive increase of phosphodiesterase isoform I and IV activities.

G Borchert1, S Bartel, I Beyerdörfer, I Küttner, L Szekeres, E G Krause.   

Abstract

Evidence is accumulating that 7-oxo-prostacyclin (7-oxo-PGI2) induces a delayed indirect anti-adrenergic and cytoprotective effect on the myocardium, the mechanism of which is still unclear. To demonstrate that a single application of 7-oxo-PGI2 (50 micrograms/kg i.m.) 48 h prior to starting experiments attenuates the isoprenaline inducible inotropic response and accumulation of cAMP, isolated hearts of pretreated animals were perfused in the Langendorff mode with and without isoprenaline (1 to 100 nM). The late anti-adrenergic effect of the drug was manifested by a significant attenuation in the elevation of cAMP levels as well as in contractile force development. This effect was not due to changes in cAMP generation as there were identical beta 1-adrenoceptor densities and affinities (as calculated from [3H]-CGP binding studies), Gi and G alpha s protein patterns (as taken from Western blots) as well as adenylyl cyclase activity measurements in the hearts studied. The anti-adrenergic potency of 7-oxo-PGI2, however, was found to be related to a significant rise in cyclic nucleotide hydrolysis by phosphodiesterase (PDE). Using the fast-performance liquid chromatographic separation for PDE isoforms, a significant increase in the activity of PDE isoforms I and IV (260 +/- 28 vs 110 +/- 12 pmol cGMP/min x enzyme fraction and 77 +/- 11 vs 34 +/- 3 pmol cAMP/min x enzyme fraction, respectively) was found in the solubilized fraction of cardiac membranes in comparison to untreated controls; PDE IV activity was also increased in the cytosolic fraction (106 +/- 14 vs 65 +/- 6 pmol cAMP/min x enzyme fraction). The hypothesis that the delayed anti-adrenergic effect of 7-oxo-PGI2 is initiated by an induction and accelerated synthesis of PDE I and IV in the heart is underlined by the fact that cycloheximide suppresses completely both the rise in PDE activities and the anti-adrenergic effects studied. It is suggested that an inducible predominance of cAMP degradation over its generation may be of relevance in processes related to heart protection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078509     DOI: 10.1007/bf00925675

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

Review 1.  Cyclic AMP phosphodiesterases and Ca2+ current regulation in cardiac cells.

Authors:  R Fischmeister; H C Hartzell
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

2.  Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.

Authors:  A M Lefer; M L Ogletree; J B Smith; M J Silver; K C Nicolaou; W E Barnette; G P Gasic
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

Review 3.  Multiple isozymes of cyclic nucleotide phosphodiesterase.

Authors:  J A Beavo
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1988

4.  An improved assay of cyclic 3',5'-nucleotide phosphodiesterases with QAE-Sephadex columns.

Authors:  A C Bauer; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

5.  7-oxo-PgI2 induced late appearing and long-lasting electrophysiological changes in the heart in situ of the rabbit, guinea-pig, dog and cat.

Authors:  L Szekeres; Z Szilvássy; E Udvary; A Végh
Journal:  J Mol Cell Cardiol       Date:  1989-06       Impact factor: 5.000

6.  The action of calcium ion on cardiac phosphorylase b kinase.

Authors:  G I Drummond; L Duncan
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

Review 7.  Cardioprotection: endogenous protective mechanisms promoted by prostacyclin.

Authors:  L Szekeres; J Pataricza; Z Szilvássy; E Udvary; A Végh
Journal:  Basic Res Cardiol       Date:  1991       Impact factor: 17.165

8.  Regulation of follicle-stimulating hormone and dibutyryl adenosine 3',5'-monophosphate of a phosphodiesterase isoenzyme of the Sertoli cell.

Authors:  M Conti; M V Toscano; L Petrelli; R Geremia; M Stefanini
Journal:  Endocrinology       Date:  1982-04       Impact factor: 4.736

9.  Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart.

Authors:  P J England
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

10.  On the late antiischaemic action of the stable PgI2 analogue: 7-oxo-PgI2-Na and its possible mode of action.

Authors:  L Szekeres; M Koltai; J Pataricza; I Takáts; E Udvary
Journal:  Biomed Biochim Acta       Date:  1984
View more
  3 in total

1.  Pharmacological induction of delayed and prolonged cardiac protection: The role of prostanoids.

Authors:  László Szekeres
Journal:  Exp Clin Cardiol       Date:  2004

2.  On the mechanism and possible therapeutic application of delayed adaptation of the heart to stress situations.

Authors:  E G Krause; L Szekeres
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

3.  Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs.

Authors:  Ralph T Schermuly; Soni S Pullamsetti; Susanne C Breitenbach; Norbert Weissmann; Hossein A Ghofrani; Friedrich Grimminger; Sigrid M Nilius; Karsten Schrör; Jutta M Kirchrath; Werner Seeger; Frank Rose
Journal:  Respir Res       Date:  2007-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.